Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New data suggests HIV superinfection rate comparable to initial HIV infection

08.06.2012
Human immunodeficiency virus (HIV) superinfection may be as common as initial HIV infection and is not limited to high risk-populations, according to a new study led by researchers at the Johns Hopkins Bloomberg School of Public Health and the National Institute of Allergy and Infectious Diseases (NIAID).

In the first large-scale study of HIV superinfection in a general heterosexual population, researchers examined the rate of superinfection among a community of sub-Saharan adults. HIV superinfection occurs when an HIV-infected individual acquires a new viral strain that is phylogenetically different from all other detectable viral strains.

Superinfection can have detrimental clinical effects as well as accelerated disease progression, and increased HIV drug resistance even among individuals who were previously controlling their HIV infection. The results are featured online in of the Journal of Infectious Diseases.

"We found it remarkable that the rates of superinfection and underlying new HIV infections were equivalent. This raises many interesting questions about the natural immune response and its inability to generate resistance to HIV reinfection," said Thomas Quinn, MD, MS, co-author of the study, an NIAID senior investigator, a professor with the Bloomberg School's Department of International Health and director of the Johns Hopkins Center for Global Health.

"For years there has been great debate regarding the rate of HIV superinfection among populations, and previous studies have focused on individuals exposed to the virus through high-risk sexual activity or intravenous drug use," said Andrew Redd, PhD, lead author of the study and a postdoctoral fellow at the Laboratory of Immunoregulation at NIAID. "We were looking to determine the rate of HIV superinfection among a broader, general population using a novel technique sensitive enough to detect even the lowest levels of circulating HIV strains."

Researchers, in collaboration with colleagues at the NIAID Rocky Mountain Laboratories, the Johns Hopkins Rakai Health Sciences Program in Kalisizo, Uganda, and Makerere University in Kampala, Uganda, used an ultra-deep sequencing technique to examine the blood samples of HIV-infected participants of the Rakai Community Cohort Study. Samples were tested at initial HIV diagnosis and at least one year later, prior to beginning antiretroviral therapy. The rate of superinfection was then compared to an estimated overall HIV incidence rate for HIV-negative individuals during this same time. Of the 149 individuals tested, Quinn and colleagues identified seven cases of HIV superinfection during follow-up and all were initially infected with some variant of HIV subtype D. In addition, the rate of superinfection was 1.44 per 100 persons and consisted of both intersubtype and intrasubtype superinfections, comparable to primary HIV incidence in initially HIV-negative individuals in the general population in Rakai.

"These results also have significant implications for estimations of the age of the HIV epidemic and for phylogenetic modeling of viral evolution because many of these models assume that superinfection is not occurring," suggest the authors. "In addition, the finding that superinfection is common and occurs within and between HIV subtypes suggests that the immune response elicited by primary infection confers limited protection and raises concerns that vaccine strategies designed to replicate the natural anti-HIV immune response may have limited effectiveness."

Redd added, "Our findings suggest that HIV vaccine strategies designed to recreate the natural immune response to HIV may be insufficient to protect an individual from infection. However, the data also provide an interesting new population to explore since it is possible that some individuals will be protected from superinfection. Determining what controls this could lead to new avenues for vaccine research."

"The Rates of HIV Superinfection and Primary HIV Incidence in a General Population in Rakai, Uganda," was written by Andrew D. Redd, Caroline E. Mullis, David Serwadda, Xiangrong Kong, Craig Martens, Stacy M. Ricklefs, Aaron A. R. Tobian, Changchang Xiao, Mary K. Grabowski, Fred Nalugoda, Godfrey Kigozi, Oliver Laeyendecker, Joseph Kagaayi, Nelson Sewankambo, Ronald H. Gray, Stephen F. Porcella, Maria J. Wawer and Thomas C. Quinn.

The research was supported in part by the National Institutes of Health and the Bill and Melinda Gates Foundation.

Natalie Wood-Wright | EurekAlert!
Further information:
http://www.jhsph.edu

More articles from Studies and Analyses:

nachricht Rutgers-led innovation could spur faster, cheaper, nano-based manufacturing
14.02.2018 | Rutgers University

nachricht New study from the University of Halle: How climate change alters plant growth
12.01.2018 | Martin-Luther-Universität Halle-Wittenberg

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Developing reliable quantum computers

International research team makes important step on the path to solving certification problems

Quantum computers may one day solve algorithmic problems which even the biggest supercomputers today can’t manage. But how do you test a quantum computer to...

Im Focus: In best circles: First integrated circuit from self-assembled polymer

For the first time, a team of researchers at the Max-Planck Institute (MPI) for Polymer Research in Mainz, Germany, has succeeded in making an integrated circuit (IC) from just a monolayer of a semiconducting polymer via a bottom-up, self-assembly approach.

In the self-assembly process, the semiconducting polymer arranges itself into an ordered monolayer in a transistor. The transistors are binary switches used...

Im Focus: Demonstration of a single molecule piezoelectric effect

Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale

Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...

Im Focus: Hybrid optics bring color imaging using ultrathin metalenses into focus

For photographers and scientists, lenses are lifesavers. They reflect and refract light, making possible the imaging systems that drive discovery through the microscope and preserve history through cameras.

But today's glass-based lenses are bulky and resist miniaturization. Next-generation technologies, such as ultrathin cameras or tiny microscopes, require...

Im Focus: Stem cell divisions in the adult brain seen for the first time

Scientists from the University of Zurich have succeeded for the first time in tracking individual stem cells and their neuronal progeny over months within the intact adult brain. This study sheds light on how new neurons are produced throughout life.

The generation of new nerve cells was once thought to taper off at the end of embryonic development. However, recent research has shown that the adult brain...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

2nd International Conference on High Temperature Shape Memory Alloys (HTSMAs)

15.02.2018 | Event News

Aachen DC Grid Summit 2018

13.02.2018 | Event News

How Global Climate Policy Can Learn from the Energy Transition

12.02.2018 | Event News

 
Latest News

The RWI/ISL-Container Throughput Index started off well in 2018

22.02.2018 | Business and Finance

FAU researchers demonstrate that an oxygen sensor in the body reduces inflammation

22.02.2018 | Health and Medicine

Histology in 3D: new staining method enables Nano-CT imaging of tissue samples

22.02.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>